Predictive Oncology Faces Delisting Concerns
Ticker: AGPU · Form: 8-K · Filed: Jun 11, 2025 · CIK: 1446159
Sentiment: bearish
Topics: delisting, compliance, regulatory
TL;DR
Predictive Oncology might get delisted - big trouble ahead.
AI Summary
Predictive Oncology Inc. filed an 8-K on June 11, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The filing also includes financial statements and exhibits, indicating potential issues with the company's compliance with stock exchange listing requirements.
Why It Matters
This filing signals potential delisting from a stock exchange, which could significantly impact the company's liquidity, investor confidence, and ability to raise capital.
Risk Assessment
Risk Level: high — The company is facing a notice of delisting or failure to meet continued listing standards, which is a severe risk to its stock market presence and operations.
Key Players & Entities
- Predictive Oncology Inc. (company) — Registrant
- June 9, 2025 (date) — Earliest event reported
- June 11, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- Skyline Medical Inc. (company) — Former company name
- Precision Therapeutics Inc. (company) — Former company name
FAQ
What specific listing rule or standard has Predictive Oncology Inc. failed to satisfy?
The filing indicates a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard' but does not specify the exact rule or standard in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 9, 2025.
What is the primary purpose of this Form 8-K filing?
The primary purpose is to report a notice of delisting or failure to satisfy a continued listing rule or standard, and to file financial statements and exhibits.
What was Predictive Oncology Inc. previously known as?
Predictive Oncology Inc. was formerly known as Skyline Medical Inc. and Precision Therapeutics Inc.
Where is Predictive Oncology Inc. incorporated and what is its business address?
The company is incorporated in Delaware and its business address is 91 43rd Street, Suite 110, Pittsburgh, PA 15201.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 11, 2025 regarding Predictive Oncology Inc. (AGPU).